New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
19:03 EDTBSXBoston Scientific clinical trial shows device programming reduces risk of death
Boston Scientific Corporation and the University of Rochester Medical Center presented positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy clinical trial that demonstrated improved programming of Boston Scientific dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator heart devices can reduce inappropriate therapy and risk of death. The study was designed to determine if alternate programming could reduce the occurrence of inappropriate therapy in primary prevention patients.
News For BSX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use